Corneal cross-linking for treatment of progressive keratoconus in various age groups.

PURPOSE To compare the effect of corneal cross-linking (CXL) for keratoconus in various age groups and to investigate the influence of the topographic cone location on the outcome of CXL. METHODS This cohort study included 95 patients (119 eyes) diagnosed as having progressive keratoconus who underwent epithelium-off standard protocol CXL from January 2010 through May 2012. For statistical analysis, patients were divided into three age groups: pediatric patients (< 18 years), adolescent patients (18 to 26 years), and adults (> 26 years). Visual acuity and refraction, topography, intraocular pressure, and endothelial cell counts were recorded preoperatively and postoperatively. RESULTS Topographic cones were located more centrally in pediatric corneas (0.85 ± 0.66 mm) compared to adolescent corneas (1.49 ± 0.76 mm, P = .002) and adult corneas (1.86 ± 0.99 mm, P < .001). Pediatric corneas flattened 1 year after CXL by a mean of 1.8 diopters (D), compared to 1.1 D in the other age groups. Central cones (0 to 1 mm) were steeper (62.3 ± 8.3 D) before treatment than peripheral cones (3 to 4 mm) (55.9 ± 8.9 D). One year after CXL, corrected distance visual acuity improved in all age groups, with the highest improvement in pediatric eyes (-0.23 ± 0.40 logMAR, P = .044). CONCLUSIONS Before CXL, cones of pediatric keratoconic corneas were located more centrally than in the two older age groups. After CXL, pediatric corneas showed more corneal flattening and more corrected distance visual acuity improvement. Pediatric CXL was equally safe compared to adolescent and adult CXL.

[1]  A. van der Lelij,et al.  A multivariate analysis and statistical model for predicting visual acuity and keratometry one year after cross-linking for keratoconus. , 2014, American journal of ophthalmology.

[2]  N. Soeters,et al.  Effective corneal collagen crosslinking in advanced cases of progressive keratoconus , 2013, Journal of cataract and refractive surgery.

[3]  R. Vinciguerra,et al.  Corneal cross-linking as a treatment for keratoconus: four-year morphologic and clinical outcomes with respect to patient age. , 2013, Ophthalmology.

[4]  J. B. Randleman,et al.  Two-year corneal cross-linking results in patients younger than 18 years with documented progressive keratoconus. , 2013, American journal of ophthalmology.

[5]  R. McDonald,et al.  Long-term follow-up of riboflavin/ultraviolet A (370 nm) corneal collagen cross-linking to halt the progression of keratoconus , 2013, British Journal of Ophthalmology.

[6]  F. Fankhauser,et al.  Riboflavin/Ultraviolet A Crosslinking of the Paracentral Cornea , 2013, Cornea.

[7]  F. Hafezi,et al.  Progression of keratoconus and efficacy of pediatric [corrected] corneal collagen cross-linking in children and adolescents. , 2012, Journal of refractive surgery.

[8]  G. Kymionis,et al.  Corneal collagen cross-linking for progressive keratoconus in pediatric patients: a feasibility study. , 2012, Journal of refractive surgery.

[9]  R. Arora,et al.  Results of corneal collagen cross-linking in pediatric patients. , 2012, Journal of refractive surgery.

[10]  J. Colin,et al.  Scalability and severity of keratoconus in children. , 2012, American journal of ophthalmology.

[11]  S. Greenstein,et al.  Effect of topographic cone location on outcomes of corneal collagen cross-linking for keratoconus and corneal ectasia. , 2012, Journal of refractive surgery.

[12]  C. Mazzotta,et al.  Riboflavin-UVA-Induced Corneal Collagen Cross-linking in Pediatric Patients , 2012, Cornea.

[13]  A. Sinha Roy,et al.  Patient-specific computational modeling of keratoconus progression and differential responses to collagen cross-linking. , 2011, Investigative ophthalmology & visual science.

[14]  C. Mazzotta,et al.  Age-Related Long-Term Functional Results after Riboflavin UV A Corneal Cross-Linking , 2011, Journal of ophthalmology.

[15]  T. Seiler,et al.  Flattening of the cornea after collagen crosslinking for keratoconus , 2011, Journal of cataract and refractive surgery.

[16]  A. van der Lelij,et al.  Corneal crosslinking for progressive keratoconus in four children. , 2011, Journal of pediatric ophthalmology and strabismus.

[17]  S. Greenstein,et al.  Corneal thickness changes after corneal collagen crosslinking for keratoconus and corneal ectasia: One‐year results , 2011, Journal of cataract and refractive surgery.

[18]  C. Mazzotta,et al.  Long-term results of riboflavin ultraviolet a corneal collagen cross-linking for keratoconus in Italy: the Siena eye cross study. , 2010, American journal of ophthalmology.

[19]  I. Aslanides,et al.  Orbscan II anterior elevation changes following corneal collagen cross-linking treatment for keratoconus. , 2009, Journal of refractive surgery.

[20]  Theo Seiler,et al.  Complication and failure rates after corneal crosslinking , 2009, Journal of cataract and refractive surgery.

[21]  A. Ertan,et al.  Keratoconus Clinical Findings According to Different Age and Gender Groups , 2008, Cornea.

[22]  D. Azar,et al.  Ectatic disorders associated with a claw-shaped pattern on corneal topography. , 2007, American journal of ophthalmology.

[23]  R. Adelman,et al.  Risk factors for progression to penetrating keratoplasty in patients with keratoconus. , 2004, American journal of ophthalmology.

[24]  T. Seiler,et al.  Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. , 2003, American journal of ophthalmology.

[25]  J. Krumeich,et al.  Live‐epikeratophakia for keratoconus , 1998, Journal of cataract and refractive surgery.

[26]  E. Spoerl,et al.  Induction of cross-links in corneal tissue. , 1998, Experimental eye research.

[27]  S. Tuft,et al.  Prognostic factors for the progression of keratoconus. , 1994, Ophthalmology.

[28]  A. Woods,et al.  The Pathology and Pathogenesis of Syphilitic Primary Optic Atrophy: A Critical Review * , 1940 .

[29]  F. Hafezi,et al.  Progression of Keratoconus and Efficacy of Pediatric Corneal Collagen Cross-linking in Children and Adolescents , 2022 .